Pharmacotherapy of congestive heart failure: An evaluation of recent advances: Postgraduate Medicine: Vol 81, No 6

Views

CrossRef citations to date

Altmetric

Preview

For many years digitalis and diuretics were the only drugs effective in treating chronic congestive heart failure. The acceptance in the past decade of vasodilating drugs and the recent advent of bipyridine derivatives represent important advances in the pharmacotherapy of congestive heart failure. Dr Alpert focuses this discussion on the clinical application of the latter two groups of drugs in treatment of left ventricular failure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pharmacotherapy of congestive heart failure

An evaluation of recent advances

Information for

Open access

Opportunities

Help and information

Pharmacotherapy of congestive heart failure

An evaluation of recent advances

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature